Profound Medical Corp. (PROF)
USD 7.06
(-2.49%)
USD 7.06
(-2.49%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 12.66 Million USD | 2.0% |
| 2022 | 12.41 Million USD | 101.67% |
| 2021 | 6.15 Million USD | -15.09% |
| 2020 | 7.25 Million USD | -53.52% |
| 2019 | 15.6 Million CAD | 6.65% |
| 2018 | 14.62 Million CAD | 33.89% |
| 2017 | 10.92 Million CAD | 65.8% |
| 2016 | 6.58 Million CAD | 26.55% |
| 2015 | 5.2 Million CAD | 4968.41% |
| 2014 | 102.73 Thousand CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 11.51 Million USD | -9.48% |
| 2024 Q2 | 10.79 Million USD | -6.34% |
| 2023 Q3 | 11.88 Million USD | -4.47% |
| 2023 Q2 | 12.44 Million USD | -0.54% |
| 2023 Q1 | 12.5 Million USD | 0.72% |
| 2023 Q4 | 12.66 Million USD | 6.58% |
| 2023 FY | 12.66 Million USD | 2.0% |
| 2022 Q3 | 3.96 Million USD | -22.92% |
| 2022 Q2 | 5.14 Million USD | -11.46% |
| 2022 Q1 | 5.81 Million USD | -5.64% |
| 2022 FY | 12.41 Million USD | 101.67% |
| 2022 Q4 | 12.41 Million USD | 213.17% |
| 2021 Q4 | 6.15 Million USD | 10.92% |
| 2021 Q2 | 5.96 Million USD | -5.95% |
| 2021 Q1 | 6.33 Million USD | -12.61% |
| 2021 Q3 | 5.55 Million USD | -6.86% |
| 2021 FY | 6.15 Million USD | -15.09% |
| 2020 Q1 | 5.27 Million CAD | -66.18% |
| 2020 Q3 | 5.43 Million CAD | 1.71% |
| 2020 Q4 | 7.25 Million USD | 33.3% |
| 2020 FY | 7.25 Million USD | -53.52% |
| 2020 Q2 | 5.34 Million CAD | 1.35% |
| 2019 FY | 15.6 Million CAD | 6.65% |
| 2019 Q3 | 14.81 Million CAD | 0.05% |
| 2019 Q1 | 15.71 Million CAD | 7.46% |
| 2019 Q2 | 14.81 Million CAD | -5.78% |
| 2019 Q4 | 15.6 Million CAD | 5.28% |
| 2018 Q2 | 7.64 Million CAD | -3.55% |
| 2018 Q3 | 14.31 Million CAD | 87.11% |
| 2018 Q4 | 14.62 Million CAD | 2.21% |
| 2018 FY | 14.62 Million CAD | 33.89% |
| 2018 Q1 | 7.93 Million CAD | -27.41% |
| 2017 Q1 | 7.44 Million CAD | 13.06% |
| 2017 Q2 | 7.16 Million CAD | -3.79% |
| 2017 Q4 | 10.92 Million CAD | 4.01% |
| 2017 Q3 | 10.5 Million CAD | 46.57% |
| 2017 FY | 10.92 Million CAD | 65.8% |
| 2016 Q1 | 5.95 Million CAD | 14.29% |
| 2016 Q2 | 6.13 Million CAD | 3.03% |
| 2016 Q4 | 6.58 Million CAD | -5.13% |
| 2016 Q3 | 6.94 Million CAD | 13.28% |
| 2016 FY | 6.58 Million CAD | 26.55% |
| 2015 Q2 | 6.18 Million CAD | 6145.89% |
| 2015 Q1 | 98.95 Thousand CAD | -17.02% |
| 2015 Q3 | 5.64 Million CAD | -8.65% |
| 2015 Q4 | 5.2 Million CAD | -7.78% |
| 2015 FY | 5.2 Million CAD | 4968.41% |
| 2014 FY | 102.73 Thousand CAD | 0.0% |
| 2014 Q4 | 119.25 Thousand CAD | 239.6% |
| 2014 Q3 | 35.11 Thousand CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Acutus Medical, Inc. | 54.83 Million USD | 76.904% |
| Axonics, Inc. | 82.35 Million USD | 84.621% |
| INVO Bioscience, Inc. | 19.99 Million USD | 36.655% |
| CVRx, Inc. | 39.28 Million USD | 67.757% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 94.321% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -298.054% |
| MaxCyte, Inc. | 36.1 Million USD | 64.921% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | 41.056% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 89.783% |
| Sintx Technologies, Inc. | 6.59 Million USD | -92.111% |
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 75.288% |
| Apyx Medical Corporation | 52.31 Million USD | 75.791% |
| Cutera, Inc. | 518.12 Million USD | 97.555% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -137.1% |
| NeuroPace, Inc. | 86.99 Million USD | 85.441% |
| IRIDEX Corporation | 24.91 Million USD | 49.162% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 85.574% |
| enVVeno Medical Corporation | 2.43 Million USD | -420.159% |
| TELA Bio, Inc. | 59.16 Million USD | 78.593% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 98.018% |
| UFP Technologies, Inc. | 118.04 Million USD | 89.27% |
| Modular Medical, Inc. | 2.27 Million USD | -457.476% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | 56.813% |
| LENSAR, Inc. | 22.4 Million USD | 43.479% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 99.423% |
| Surmodics, Inc. | 65.82 Million USD | 80.758% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -22.743% |
| Inogen, Inc. | 121.38 Million USD | 89.565% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -656.623% |
| RxSight, Inc. | 22.18 Million USD | 42.916% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -2878.234% |
| Lucid Diagnostics Inc. | 29.58 Million USD | 57.182% |
| Nano-X Imaging Ltd. | 23.13 Million USD | 45.25% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -2878.234% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -421.379% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 87.892% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 98.2% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | 50.258% |
| Dynatronics Corporation | 11.78 Million USD | -7.519% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 75.484% |
| InMode Ltd. | 75.91 Million USD | 83.316% |
| Bruker Corporation | 2.83 Billion USD | 99.553% |
| Movano Inc. | 5.97 Million USD | -112.087% |
| Orthofix Medical Inc. | 326.58 Million USD | 96.122% |
| FONAR Corporation | 57.45 Million USD | 77.956% |
| BioSig Technologies, Inc. | 4.68 Million USD | -170.349% |
| Envoy Medical, Inc. | 9.4 Million USD | -34.715% |
| Align Technology, Inc. | 2.45 Billion USD | 99.484% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 78.3% |
| Talis Biomedical Corporation | 29.22 Million USD | 56.659% |
| Cerus Corporation | 144.3 Million USD | 91.223% |
| 908 Devices Inc. | 37.49 Million USD | 66.215% |
| Nemaura Medical Inc. | 26.37 Million USD | 51.982% |
| Outset Medical, Inc. | 190.91 Million USD | 93.366% |
| NanoVibronix, Inc. | 2.68 Million USD | -371.551% |
| Venus Concept Inc. | 107.1 Million USD | 88.174% |
| Telesis Bio, Inc. | 40.87 Million USD | 69.012% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 88.887% |
| Quipt Home Medical Corp. | 136.29 Million USD | 90.707% |
| IRadimed Corporation | 20.73 Million USD | 38.918% |
| Tenon Medical, Inc. | 5.56 Million USD | -127.517% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -254.587% |
| Pulmonx Corporation | 60.63 Million USD | 79.112% |
| iCAD, Inc. | 8 Million USD | -58.304% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | 0.194% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -585.416% |
| Viemed Healthcare, Inc. | 40.79 Million USD | 68.949% |
| SI-BONE, Inc. | 61.05 Million USD | 79.253% |
| Semler Scientific, Inc. | 6.27 Million USD | -102.007% |
| Biotricity, Inc. | 35.91 Million USD | 64.738% |
| Cytosorbents Corporation | 29.98 Million USD | 57.76% |
| DexCom, Inc. | 4.19 Billion USD | 99.698% |
| ZimVie Inc. | 795.85 Million USD | 98.409% |
| Aethlon Medical, Inc. | 2.47 Million USD | -410.792% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -5.919% |
| IceCure Medical Ltd | 4.24 Million USD | -198.231% |
| PAVmed Inc | 57.13 Million USD | 77.832% |
| Sight Sciences, Inc. | 46.43 Million USD | 72.724% |
| Insulet Corporation | 1.85 Billion USD | 99.317% |
| electroCore, Inc. | 8.94 Million USD | -41.597% |
| Bioventus Inc. | 589.79 Million USD | 97.852% |
| InspireMD, Inc. | 8.14 Million USD | -55.562% |
| PAVmed Inc. | 57.13 Million USD | 77.832% |
| Nuwellis, Inc. | 6.78 Million USD | -86.812% |
| OrthoPediatrics Corp. | 72.56 Million USD | 82.545% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -5.919% |
| BrainsWay Ltd. | 15.31 Million USD | 17.292% |
| BIOLASE, Inc. | 35.34 Million USD | 64.168% |
| Beyond Air, Inc. | 29.77 Million USD | 57.461% |
| AxoGen, Inc. | 101.16 Million USD | 87.48% |
| Inari Medical, Inc. | 209.32 Million USD | 93.949% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -479.458% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -611.965% |
| AdaptHealth Corp. | 3.15 Billion USD | 99.598% |
| Quanterix Corporation | 78.08 Million USD | 83.779% |
| Viveve Medical, Inc. | 10.84 Million USD | -16.768% |
| LivaNova PLC | 1.15 Billion USD | 98.9% |
| Co-Diagnostics, Inc. | 17.63 Million USD | 28.174% |
| Varex Imaging Corporation | 668.6 Million USD | 98.106% |
| Vivani Medical, Inc. | 25.03 Million USD | 49.409% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -211.66% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -254.587% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -159.281% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 98.788% |
| TransMedics Group, Inc. | 568.84 Million USD | 97.773% |
| ReWalk Robotics Ltd. | 16.68 Million USD | 24.075% |
| NeuroMetrix, Inc. | 1.33 Million USD | -850.089% |
| Spectral AI, Inc. | 12.4 Million USD | -2.136% |
| Hyperfine, Inc. | 9.8 Million USD | -29.244% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 94.939% |
| Biomerica, Inc. | 2.66 Million USD | -375.624% |
| Bone Biologics Corporation | 831.4 Thousand USD | -1423.434% |
| AVITA Medical, Inc. | 19.86 Million USD | 36.242% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -541.738% |
| Silk Road Medical, Inc | 114.15 Million USD | 88.905% |